Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma

NCT06279767 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Cancer
Temozolomide

Interventions

DRUG: 6-mercaptopurine

Sponsor

The First Affiliated Hospital with Nanjing Medical University